SYNGENE INTERNATIONAL Financial Statement Analysis
|
||
|
The Revenues of SYNGENE INTERNATIONAL have increased by 4.71% YoY .
The Earnings Per Share (EPS) of SYNGENE INTERNATIONAL has decreased by -36.25 % YoY. |
||
SYNGENE INTERNATIONAL Last 5 Annual Financial Results
[BOM: 539268|NSE : SYNGENE]
| Consolidated | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Operating Income | ₹3,657 Cr | ₹3,492 Cr | ₹3,197 Cr | ₹2,604 Cr | ₹2,184 Cr |
| Operating Expenses | ₹1,184 Cr | ₹1,082 Cr | ₹1,079 Cr | ₹914 Cr | ₹682 Cr |
| Expenses | ₹2,601 Cr | ₹2,474 Cr | ₹2,260 Cr | ₹1,864 Cr | ₹1,531 Cr |
| Operating Profit (Excl OI) | ₹1,042 Cr | ₹1,014 Cr | ₹933 Cr | ₹741 Cr | ₹653 Cr |
| Other Income | ₹72 Cr | ₹91 Cr | ₹73 Cr | ₹108 Cr | ₹83 Cr |
| Interest | ₹53 Cr | ₹47 Cr | ₹45 Cr | ₹24 Cr | ₹28 Cr |
| Depreciation | ₹433 Cr | ₹426 Cr | ₹367 Cr | ₹310 Cr | ₹275 Cr |
| Profit Before Tax | ₹660 Cr | ₹621 Cr | ₹594 Cr | ₹484 Cr | ₹469 Cr |
| Profit After Tax | ₹496 Cr | ₹510 Cr | ₹464 Cr | ₹396 Cr | ₹405 Cr |
| Consolidated Net Profit | ₹496 Cr | ₹510 Cr | ₹464 Cr | ₹396 Cr | ₹405 Cr |
| Earnings Per Share (Rs) | ₹7.86 | ₹12.33 | ₹12.69 | ₹11.57 | ₹9.88 |
| PAT Margin (%) | 8.43 | 13.57 | 14.60 | 14.53 | 15.20 |
| ROE(%) | 6.74 | 11.23 | 13.18 | 13.73 | 13.29 |
| ROCE(%) | 9.48 | 15.42 | 15.55 | 15.43 | 13.24 |
| Total Debt/Equity(x) | 0.00 | 0.03 | 0.03 | 0.16 | 0.25 |
Key Financials |
||
| Market Cap | : | ₹ 16,711.2 Cr |
| Revenue (TTM) | : | ₹ 3,738.7 Cr |
| Net Profit(TTM) | : | ₹ 316.7 Cr |
| EPS (TTM) | : | ₹ 7.8 |
| P/E (TTM) | : | 52.8 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| SYNGENE INTERNATIONAL | -0.1% | -5.1% | -38.2% |
| SAGILITY | 3.4% | 7.2% | -8.4% |
| PRIME FOCUS | -0.7% | 37.8% | 72% |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | -3.8% | -8.2% | -13.2% |
| INDEGENE | 0% | -2.1% | -14.2% |
| NESCO | -6.6% | -7.4% | -17.8% |
| LATENT VIEW ANALYTICS | 2.9% | 5.2% | -32.7% |
| SUN PHARMA ADVANCED RESEARCH COMPANY | -4.3% | -4.3% | 34.5% |
| CMS INFO SYSTEMS | -0.9% | -6.4% | -48.6% |
SYNGENE INTERNATIONAL Revenues
[BOM: 539268|NSE : SYNGENE]
| Y-o-Y | 4.71 % |
| 5 Yr CAGR | 13.75 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,657 Cr | 4.71 | |
| Mar2025 | ₹3,492 Cr | 9.26 | |
| Mar2024 | ₹3,197 Cr | 22.74 | |
| Mar2023 | ₹2,604 Cr | 19.22 | |
| Mar2022 | ₹2,184 Cr | - | |
SYNGENE INTERNATIONAL Operating Profit
[BOM: 539268|NSE : SYNGENE]
| Y-o-Y | 2.70 % |
| 5 Yr CAGR | 12.38 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,042 Cr | 2.70 | |
| Mar2025 | ₹1,014 Cr | 8.76 | |
| Mar2024 | ₹933 Cr | 25.96 | |
| Mar2023 | ₹741 Cr | 13.38 | |
| Mar2022 | ₹653 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -1.93 % |
| 5 Yr CAGR | -1.20 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 28.49% | -1.93 | |
| Mar2025 | 29.05% | -0.45 | |
| Mar2024 | 29.18% | 2.64 | |
| Mar2023 | 28.43% | -4.92 | |
| Mar2022 | 29.9% | - | |
SYNGENE INTERNATIONAL Profit After Tax
[BOM: 539268|NSE : SYNGENE]
| Y-o-Y | -2.71 % |
| 5 Yr CAGR | 5.21 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹496 Cr | -2.71 | |
| Mar2025 | ₹510 Cr | 9.82 | |
| Mar2024 | ₹464 Cr | 17.33 | |
| Mar2023 | ₹396 Cr | -2.25 | |
| Mar2022 | ₹405 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -37.88 % |
| 5 Yr CAGR | -13.70 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 8.43 % | -37.88 | |
| Mar2025 | 13.57 % | -7.05 | |
| Mar2024 | 14.6 % | 0.48 | |
| Mar2023 | 14.53 % | -4.41 | |
| Mar2022 | 15.2 % | - | |
SYNGENE INTERNATIONAL Earnings Per Share (EPS)
[BOM: 539268|NSE : SYNGENE]
| Y-o-Y | -36.25 % |
| 5 Yr CAGR | -5.56 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹7.86 | -36.25 | |
| Mar2025 | ₹12 | -2.84 | |
| Mar2024 | ₹13 | 9.68 | |
| Mar2023 | ₹12 | 17.11 | |
| Mar2022 | ₹9.88 | - | |
SYNGENE INTERNATIONAL Return on Capital Employed (ROCE)
[BOM: 539268|NSE : SYNGENE]
| Y-o-Y | -38.52 % |
| 5 Yr CAGR | -8.01 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 9.48% | -38.52 | |
| Mar2025 | 15.42% | -0.84 | |
| Mar2024 | 15.55% | 0.78 | |
| Mar2023 | 15.43% | 16.54 | |
| Mar2022 | 13.24% | - | |
SYNGENE INTERNATIONAL Share Price vs Sensex
| Current Share Price | : | ₹414.0 |
| Current MarketCap | : | ₹ 16,711.2 Cr |
| Updated EOD on | : | Jul 27,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNGENE INTERNATIONAL | -0.1% |
-5.1% |
-38.2% |
| SENSEX | -1.1% |
-0.2% |
-6.6% |
SYNGENE INTERNATIONAL related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE HEALTHCARE | -0.3% | 3.3% | 10.5% |
| BSE SMALLCAP SELECT INDEX | -0.3% | 0% | 5% |
| BSE 1000 | -0.8% | 0.2% | -1.2% |
| BSE 500 | -0.8% | 0.2% | -1.5% |
| BSE 400 MIDSMALLCAP INDEX | -1% | 0.4% | 1.1% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY MIDSMALL HEALTHCARE | 0.1% | 4.3% | 13% |
| NIFTY HEALTHCARE INDEX | -0.1% | 3.3% | 11.6% |
| NIFTY500 HEALTHCARE INDEX | -0.3% | 3.3% | 10.2% |
| NIFTY500 SHARIAH | -0.4% | 0.6% | -4.2% |
| NIFTY SMALLCAP 500 | -0.7% | 0.3% | NA |
You may also like the below Video Courses
FAQ about SYNGENE INTERNATIONAL Financials
How the annual revenues of SYNGENE INTERNATIONAL have changed ?
The Revenues of SYNGENE INTERNATIONAL have increased by 4.71% YoY .
How the Earnings per Share (EPS) of SYNGENE INTERNATIONAL have changed?
The Earnings Per Share (EPS) of SYNGENE INTERNATIONAL has decreased by -36.25 % YoY .
Check out Intrinsic Value of Peers of SYNGENE INTERNATIONAL
Compare Stock Analytics of Peers of SYNGENE INTERNATIONAL
SAGILITY LTD vs SYNGENE INTERNATIONAL LTD vs PRIME FOCUS LTD
INTERNATIONAL GEMOLOGICAL INSTITUTE LTD vs INDEGENE LTD vs
SAGILITY LTD vs SYNGENE INTERNATIONAL LTD vs PRIME FOCUS LTD
INTERNATIONAL GEMOLOGICAL INSTITUTE LTD vs INDEGENE LTD vs
